(KNSA) – Hot Corp. News
-
Kiniksa Pharmaceuticals (KNSA) Announces Global License Agreement with Genentech for Vixarelimab
-
Kiniksa Pharmaceuticals Ltd. (KNSA) Announces Phase 3 Trial of Mavrilimumab in COVID-19-Related ARDS Did Not Meet Endpoints
-
-
Back to KNSA Stock Lookup